Table 3.
Cardiac findings in patient with or without myocardial injury
| TnI+(n = 20) | TnI-(n = 12) | P-value | |
|---|---|---|---|
| BNP (pc/mL) | 891 ± 988 | 146 ± 120 | 0.03* |
| PCR (mg/L) | 188 ± 100 | 118 ± 53 | 0.016* |
| PCT (ng/mL) | 48.8 ± 103 | 19.8 ± 36 | 0.22 |
| VES (mm/h) | 56 ± 35 | 51 ± 40 | 0.73 |
| D-dimer (mcg/mL) | 1827 ± 2717 | 2473 ± 2085 | 0.19 |
| SARS-CoV-2 Ig title (kAU/L) | 11.5 ± 28.1 | 10.3 ± 8.6 | 0.12 |
| LVEF echo (%) | 55 ± 10 | 64 ± 8 | 0.032* |
| GLS (%) | −16.3 ± 4.2 | −19.3 ± 3.2 | 0.02* |
| E/A | 2 ± 0.66 | 1.7 ± 0.57 | 0.14 |
| E/e’ average | 8.1 ± 1.7 | 7.5 ± 2.2 | 0.42 |
| TAPSE (mm) | 19.5 ± 5.3 | 18.1 ± 4 | 0.44 |
| RV FAC (%) | 44.8 ± 7.7 | 40.3 ± 6 | 0.15 |
| Coronary dilatation | 6 (30) | 3 (25) | 0.76 (X2 0.09, p 1 FET) |
| Pericardial effusion | 4 (20) | 5 (42) | 0.18 (X2 1.7) |
| CMR (n = 23) | TnI+(n = 17) | TnI-(n = 6) | P-value |
| CMR LVEF (%) | 59.4 ± 11.4 | 64 ± 1.3 | 0.38 |
| CMR LV LGE | 5 (30) | 3 (50) | 0.36 (X2 0.82, p 0.62 FET) |
Values are numbers (%) or mean ± standard deviation.
BNP, brain natriuretic peptide; CRP, C-reactive protein; ERS, erythrocyte sedimentation rate); GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; LV LGE, left ventricular late gadolinium enhancement; MIS-C, multisystem inflammatory syndrome in children; PCT, procalcitonin; RV FAC, right ventricular fractional area change; RVEF, right ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion; TnI, troponin I. * = P < 0.05.